Pharmabiz17m
BFI partners with CSIR- CDRI to advance biomedical innovation
BFI partners with CSIR- CDRI to advance biomedical innovation: Our Bureau, Mumbai Saturday, September 28, 2024, 14:45 Hrs [IST] CSIR-Central Drug Research Institute (CDRI), a prem ...
Pharmabiz43m
CK Birla Hospitals unveils ‘Every Beat Counts’ report: A first-of-its-kind insight into India’s cardiac health crisis
BM Birla Heart Hospital (BMB), part of CK Birla Hospitals, has launched a first of its kind report on India’s cardiac health – ‘Every Beat Counts’. This report not only sheds light on the cardiac ...
Pharmabiz1h
World leaders commit to decisive action on antimicrobial resistance
World leaders commit to decisive action on antimicrobial resistance: Geneva Saturday, September 28, 2024, 14:00 Hrs [IST] Global leaders have approved a political declaration at t ...
Pharmabiz1h
Corning launches rabies awareness campaign with Serum Institute and SEWA India on World Rabies Day
Corning launches rabies awareness campaign with Serum Institute and SEWA India on World Rabies Day: Our Bureau, Mumbai Saturday, September 28, 2024, 13:45 Hrs [IST] Corning Incorp ...
Pharmabiz1h
Our vision is a cancer-free future generation, where everyone has access to accurate tests and affordable treatment: Meghalaya health minister
Our Bureau, Mumbai Saturday, September 28, 2024, 13:30 Hrs [IST] ...
Pharmabiz1h
CDSCO declares 59 drugs tested in August as Not of Standard Quality
The Central Drugs Standard Control Organisation (CDSCO) has released a list of 59 drug samples declared as Not of Standard Quality (NSQ) during the month of August, with samples of drugs labelled as ...
Pharmabiz1h
Pharma associations in TN to organise interactive meeting with regulatory officers prior to preliminary inspections
Giving full support to the endeavours being initiated by the regulatory department of Tamil Nadu in implementing the Revised Schedule M in the pharma sector, the pharmaceutical industry in the state ...
Pharmabiz2h
Omeicos Therapeutics completes enrollment in phase 2a PMD-OPTION study of OMT-28 in primary mitochondrial disease
Omeicos Therapeutics completes enrollment in phase 2a PMD-OPTION study of OMT-28 in primary mitochondrial disease: Berlin, Germany Saturday, September 28, 2024, 13:00 Hrs [IST] Om ...
Pharmabiz3h
Evotec enters technology development partnership with Novo Nordisk in cell therapy
Evotec SE, a life science company, has entered a technology development partnership with Novo Nordisk in cell therapy. Both Evotec and Novo Nordisk have significant expertise and a strategic focus to ...
Pharmabiz4h
Enterprise Therapeutics’ novel cystic fibrosis investigational therapy, ETD001 receives rare paediatric disease designation in US
Enterprise Therapeutics’ novel cystic fibrosis investigational therapy, ETD001 receives rare paediatric disease designation in US: Brighton, England Saturday, September 28, 2024 ...
Pharmabiz5h
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome: Leiden, the Netherlands Saturday, September 28, 2024, ...
Pharmabiz6h
US FDA approves Bristol-Myers Squibb’s antipsychotic drug, Cobenfy for treatment of schizophrenia
US FDA approves Bristol-Myers Squibb’s antipsychotic drug, Cobenfy for treatment of schizophrenia: Maryland Saturday, September 28, 2024, 09:00 Hrs [IST] The US Food and Drug Ad ...